Compound: TESTOSTERONE CYPIONATE
SMILES: O=C1C=C2[C@]([C@@H]3[C@H]([C@H]4[C@]([C@@H](OC(=O)CCC5CCCC5)CC4)(C)CC3)CC2)(C)CC1
InChIKey: HPFVBGJFAYZEBE-ZLQWOROUSA-N
Synonyms: TESTOSTERONE CYPIONATE, 58-20-8, Depo-Testosterone, Depovirin, Pertestis, Testosterone cyclopentylpropionate, Testosterone cyclopentanepropionate, Andro-Cyp, Testosterone 17beta-cypionate, Testosterone cipionate, Depotest, Testosterone cypionate ciii, Depo-Testosterone cypionate, M0XW1UBI14, Testosterone 17beta-cyclopentylpropionate, DTXSID901015617, NSC-9157, Testosterone cypionate (USP), Testosterone cypionate [USP], Testosterone 17beta-cyclopentanepropionate, CHEBI:9463, 17-(3-cyclopentyl-1-propionyl)-17beta-hydroxyandrost-4-en-3-one, Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17beta)-, NSC9157, depAndro, AZMIRO, RefChem:56105, testosterone cypionate inj., 17Beta-Cyclopentanepropionate, TESTO-200, Testosterone Cypionate Injection, DTXCID001473854, 200-368-4, Jectatest, Dep-Test, Malogen CYP, depAndro 100, depAndro 200, T-Ionate-P.A, Testodrin prolongatum, Durandro, NSC 9157, Testosterone 17.beta.-cyclopentanepropionate, Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17b)-, Testosterone, cyclopentanepropionate, Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17.beta.)-, [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate, 3-oxoandrost-4-en-17beta-yl 3-cyclopentylpropanoate, Testosterone Cypionate (1mg/ml in Acetonitrile), UNII-M0XW1UBI14, Testosterone 17.beta.-cypionate, Testosterone 17-beta-cypionate, (1S,3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl 3-cyclopentylpropanoate, EINECS 200-368-4, Testosterone 17.beta.-cyclopentylpropionate, Depo-testosterone cyclopentylpropionate, BRN 3174363, Depo-testosterone (TN), Testosterone Impurity 121, SCHEMBL40862, (8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate, 17beta-Hydroxyandrost-4-en-3-one cyclopentylpropionate, CHEMBL1201101, LMST02020074, MFCD00053944, TESTOSTERONE CYPIONATE [VANDF], AKOS007930349, AKOS015895326, TESTOSTERONE CIPIONATE [MART.], DB13943, DS-3318, TESTOSTERONE CIPIONATE [WHO-DD], FT156864, TESTOSTERONE CYPIONATE [ORANGE BOOK], TESTOSTERONE CYPIONATE CIII [USP-RS], TESTOSTERONE CYPIONATE [USP MONOGRAPH], C08156, D00957, AB01274709-01, Testosterone Cypionate (1 mg/ml in Acetonitrile), DEPO-TESTADIOL COMPONENT TESTOSTERONE CYPIONATE, Q27108401, Testosterone cypionate 100 microg/mL in Acetonitrile, 17.beta.-Hydroxyandrost-4-en-3-one cyclopentylpropionate, TESTOSTERONE 17.BETA.-CYCLOPENTANEPROPIONATE [MI], 17-(Cyclopentyl-1-oxopropoxy)androst-4-en-3-one, (17.beta.)-, 3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate, (17.beta.)- #, Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard
Theoretical properties:
molecular_formula: C27H40O3
molecular_weight: 412.6 g/mol
exact_mass: 412.29774513 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 5
heavy_atom_count: 30
topological_polar_surface_area: 43.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
melting_point: 98-104ºC
solubility: Insoluble
Descriptions:
{"pubchem": "Testosterone Cypionate can cause developmental toxicity according to state or federal government labeling requirements.", "chebi": null, "chembl": "TESTOSTERONE CYPIONATE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.", "wikipedia": "Testosterone cypionate, sold under the brand name Depo-Testosterone among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men, including hormone therapy for transgender men. It is given by injection into muscle or subcutaneously, once every one to four weeks, depending on clinical indication.\nSide effects of testosterone cypionate include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. Testosterone supplementation is also known to reduce the threshold for aggressive behavior in men. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). Testosterone cypionate is converted by the body to testosterone that has both androgenic effects and anabolic effects, which make it useful for producing masculinization and suitable for androgen replacement therapy; still, the relative potency of these effects can depend on various factors and is a topic of ongoing research. Testosterone can either directly exert effects on target tissues or be metabolized by 5\u03b1-reductase into DHT or aromatized to estradiol (E2). Both testosterone and DHT bind to an androgen receptor(AR); however, DHT has a stronger binding affinity than testosterone and may have more androgenic effect in certain tissues at lower levels. Testosterone cypionate is a testosterone ester and a long-lasting prodrug of testosterone in the body. Because of this, it is considered to be a natural and bioidentical form of testosterone.\nTestosterone cypionate was introduced for medical use in 1951. Along with testosterone enanthate, testosterone undecanoate, and testosterone propionate, it is one of the most commonly used testosterone esters. It is used mainly in the United States. In addition to its medical use, testosterone cypionate is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit."}